[go: up one dir, main page]

NO990283L - Formulering for behandling og/eller profylakse av demens - Google Patents

Formulering for behandling og/eller profylakse av demens

Info

Publication number
NO990283L
NO990283L NO990283A NO990283A NO990283L NO 990283 L NO990283 L NO 990283L NO 990283 A NO990283 A NO 990283A NO 990283 A NO990283 A NO 990283A NO 990283 L NO990283 L NO 990283L
Authority
NO
Norway
Prior art keywords
dementia
treatment
prophylaxis
formulation
pharmaceutically acceptable
Prior art date
Application number
NO990283A
Other languages
English (en)
Norwegian (no)
Other versions
NO990283D0 (no
Inventor
Dirk Marinus J Van Schie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990283D0 publication Critical patent/NO990283D0/no
Publication of NO990283L publication Critical patent/NO990283L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO990283A 1996-07-25 1999-01-22 Formulering for behandling og/eller profylakse av demens NO990283L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (2)

Publication Number Publication Date
NO990283D0 NO990283D0 (no) 1999-01-22
NO990283L true NO990283L (no) 1999-03-19

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990283A NO990283L (no) 1996-07-25 1999-01-22 Formulering for behandling og/eller profylakse av demens

Country Status (23)

Country Link
EP (1) EP0918521B1 (es)
JP (1) JP2000515868A (es)
KR (1) KR20000029523A (es)
CN (1) CN1226163A (es)
AR (1) AR007983A1 (es)
AT (1) ATE224711T1 (es)
BR (1) BR9710546A (es)
CA (1) CA2261233A1 (es)
CO (1) CO5031290A1 (es)
CZ (1) CZ22799A3 (es)
DE (1) DE69715878T2 (es)
DK (1) DK0918521T3 (es)
ES (1) ES2184121T3 (es)
GB (1) GB9615628D0 (es)
IL (1) IL128095A (es)
NO (1) NO990283L (es)
NZ (1) NZ333704A (es)
PL (1) PL331283A1 (es)
PT (1) PT918521E (es)
TR (1) TR199900141T2 (es)
TW (1) TW426514B (es)
WO (1) WO1998004258A1 (es)
ZA (1) ZA976592B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
KR100854213B1 (ko) * 2000-09-27 2008-08-26 디에스엠 아이피 어셋츠 비.브이. 콘쥬게이션 디엔의 카르보닐화 방법
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
WO2019128918A1 (zh) 2017-12-29 2019-07-04 广州再极医药科技有限公司 芳香乙烯或芳香乙基类衍生物、其制备方法、中间体、药物组合物及应用
WO2026018155A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with long-acting non-cns penetrant muscarinic antagonists
WO2026018154A1 (en) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinations of sabcomeline with non-cns penetrant muscarinic antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034146T2 (de) * 1989-04-13 2005-07-14 Beecham Group P.L.C., Brentford Chemische Verbindungen
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ES2184121T3 (es) 2003-04-01
WO1998004258A1 (en) 1998-02-05
TR199900141T2 (xx) 1999-03-22
EP0918521A1 (en) 1999-06-02
ZA976592B (en) 1999-03-04
AU721101B2 (en) 2000-06-22
EP0918521B1 (en) 2002-09-25
BR9710546A (pt) 1999-08-17
TW426514B (en) 2001-03-21
KR20000029523A (ko) 2000-05-25
DE69715878T2 (de) 2003-05-22
PL331283A1 (en) 1999-07-05
DE69715878D1 (de) 2002-10-31
IL128095A (en) 2002-07-25
HK1021314A1 (en) 2000-06-09
GB9615628D0 (en) 1996-09-04
DK0918521T3 (da) 2003-02-03
JP2000515868A (ja) 2000-11-28
IL128095A0 (en) 1999-11-30
PT918521E (pt) 2003-02-28
CA2261233A1 (en) 1998-02-05
CO5031290A1 (es) 2001-04-27
NO990283D0 (no) 1999-01-22
ATE224711T1 (de) 2002-10-15
CZ22799A3 (cs) 1999-06-16
CN1226163A (zh) 1999-08-18
AU3768497A (en) 1998-02-20
NZ333704A (en) 2000-06-23
AR007983A1 (es) 1999-11-24

Similar Documents

Publication Publication Date Title
AU2725392A (en) Hiv protease inhibitors
CA2179540A1 (en) Accelerated release composition containing bromocriptine
IL111365A0 (en) (r)-5-carbamoyl -8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1- benzopyrans
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
AU1266288A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
UA41355C2 (uk) Засіб для лікування нейро-сніду
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
ATE219061T1 (de) Huperzin a analoge verbindungen
DK393188D0 (da) Farmaceutisk praeparat til intranasal administrering
NO892820L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive amidino-og guanidino-derivater.
NO990283L (no) Formulering for behandling og/eller profylakse av demens
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
CA2120319A1 (en) Pharmaceutical for the treatment of skin disorders
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
AU4685389A (en) Pharmaceutical compositions and use thereof in the treatment of psoriasis
AU6970394A (en) Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
WO1996000068A3 (en) Combination therapy for hiv infection
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
NO922635L (no) Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension